Heron Therapeuti (HRTX) — Strategic Asset Allocation Index
Heron Therapeuti (HRTX) has a Strategic Asset Allocation Index of 219.6% as of December 2022. Strategic assets (PP&E of $29.80 Million plus long-term investments of $-) total $29.80 Million, measured against net assets of $13.57 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see Heron Therapeuti (HRTX) market capitalisation.
SAAI
Strategic Assets
PP&E
Net Assets
Heron Therapeuti Strategic Asset Allocation Index (2000–2022)
This chart shows how Heron Therapeuti's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of December 2022, the index stands at 219.6%, representing strategic assets of $29.80 Million against net assets of $13.57 Million USD. See debt-free asset ratio of Heron Therapeuti to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Heron Therapeuti (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Heron Therapeuti from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore Heron Therapeuti net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 219.6% | $29.80 Million | $29.80 Million | $- | $13.57 Million | ▲ +176.3 pp |
| 2021 | 43.3% | $33.56 Million | $33.56 Million | $- | $77.57 Million | ▲ +33.7 pp |
| 2020 | 9.6% | $22.74 Million | $22.74 Million | $- | $236.49 Million | ▲ +4.8 pp |
| 2019 | 4.9% | $19.62 Million | $19.62 Million | $- | $403.83 Million | ▲ +0.9 pp |
| 2018 | 4.0% | $14.68 Million | $14.68 Million | $- | $370.16 Million | ▼ -0.6 pp |
| 2017 | 4.6% | $5.98 Million | $5.98 Million | $- | $131.14 Million | ▲ +2.0 pp |
| 2015 | 2.6% | $3.05 Million | $3.05 Million | $- | $118.11 Million | ▼ -1.9 pp |
| 2014 | 4.5% | $2.82 Million | $2.82 Million | $- | $63.06 Million | ▲ +0.3 pp |
| 2013 | 4.2% | $2.88 Million | $2.88 Million | $- | $68.94 Million | ▲ +0.8 pp |
| 2012 | 3.4% | $1.75 Million | $1.75 Million | $- | $51.82 Million | ▼ -3.4 pp |
| 2011 | 6.8% | $1.07 Million | $1.07 Million | $- | $15.75 Million | ▼ -20.3 pp |
| 2010 | 27.1% | $357.00K | $357.00K | $- | $1.32 Million | ▲ +19.6 pp |
| 2009 | 7.5% | $510.00K | $510.00K | $- | $6.80 Million | ▼ -4.1 pp |
| 2008 | 11.6% | $881.00K | $881.00K | $- | $7.60 Million | ▲ +7.9 pp |
| 2007 | 3.7% | $1.08 Million | $1.08 Million | $- | $29.47 Million | ▼ -4.3 pp |
| 2006 | 7.9% | $958.00K | $958.00K | $- | $12.06 Million | ▼ -10.8 pp |
| 2005 | 18.8% | $1.16 Million | $1.16 Million | $- | $6.20 Million | ▲ +10.0 pp |
| 2004 | 8.7% | $1.24 Million | $1.24 Million | $- | $14.15 Million | ▼ -4.0 pp |
| 2003 | 12.7% | $1.43 Million | $1.43 Million | $- | $11.26 Million | ▲ +2.1 pp |
| 2002 | 10.6% | $1.64 Million | $1.64 Million | $- | $15.46 Million | ▲ +1.9 pp |
| 2001 | 8.7% | $1.67 Million | $1.67 Million | $- | $19.17 Million | ▲ +0.2 pp |
| 2000 | 8.5% | $1.79 Million | $1.79 Million | $- | $21.16 Million | — |